Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Gilead Sciences Inc
483
•Gilead Sciences Inc•February 12, 2010

Gilead Sciences Inc – FDA 483, Feb 12, 2010

Record Details

This FDA Form 483 documents observations from an inspection related to the aseptic processing of drug products. The facility exhibits deficiencies in several areas.

Regarding facility and operations, separate or defined areas to prevent contamination or mix-ups are inadequate for aseptic processing. The system for monitoring environmental conditions in aseptic processing areas is deficient, as are systems for maintaining equipment used to control aseptic conditions. Buildings used for holding drug products are not maintained in a good state of repair.

Quality system and manufacturing issues include equipment and utensils not being cleaned and sanitized at appropriate intervals to prevent contamination. Procedures designed to prevent microbiological contamination of sterile drug products are not followed, and these procedures lack adequate validation of the sterilization process.

Laboratory controls are deficient, specifically in the establishment of scientifically sound and appropriate sampling plans and test procedures to assure drug product conformity to standards of identity, strength, quality, and purity. Acceptance criteria for sampling and testing by the quality control unit are inadequate to assure batches meet specifications and statistical quality control criteria for release. Finally, written procedures for annual evaluations of batch records (approved or rejected) are not followed.

Company
Gilead Sciences Inc
Inspection date
February 12, 2010
Product type
Drugs
Office
Los Angeles District Office
Person
  • Carla J. Lundi (Senior Consumer Safety Officer)
View Company Profile

ID · 5cec8b9b-bf8c-46d3-877a-4e521fa22a0e

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gilead Sciences Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.